Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

GHRP-6 CJC-1295 NO DAC

£17.65£26.63

Buy GHRP-6 CJC-1295 No DAC 2.5mg Vial Blend

Buy GHRP-6 CJC-1295 No DAC 2.5mg peptide vial, a blend of the synthetic peptides GHRP-6 and CJC-1295 without DAC (Drug Affinity Complex). GHRP-6 acts as a synthetic ghrelin agonist, interacting with the growth hormone secretagogue receptor to stimulate the release of growth hormone. CJC-1295 NO DAC is a modified version of growth hormone-releasing hormone (GHRH) that can increase plasma growth hormone levels, with this particular blend often used in research for potential benefits in muscle building and fat loss.

CJC-1295 NO DAC = 0.8mg | GHRP-6 = 1.7mg

Buy 10 and get 10% Discount

452 in stock

Description

Buy GHRP-6 CJC-1295 NO DAC 2.5mg Blend Peptide Vial

This product is intended for research purposes only. To be used by trained professionals only.

GHRP-6 CJC-1295 NO DAC is a blend of two synthetic peptides, GHRP-6 and CJC-1295 without DAC (Drug Affinity Complex), that act synergistically to stimulate the release of growth hormone. This blend has been suggested to have potential benefits for muscle growth, fat loss, sleep, and immune function. However, more research is needed to validate these claims and to assess the safety and efficacy of this peptide blend in humans.

GHRP-6

GHRP-6, or Growth Hormone Releasing Peptide-6, is a hexapeptide that functions as a secretagogue, signalling the pituitary gland to produce more growth hormone [1]. It’s known for its ability to stimulate hunger by mimicking the hormone ghrelin, which regulates appetite and energy homeostasis.

This peptide also promotes the release of naturally occurring growth hormone, leading to an increase in muscle mass and a reduction in body fat. Visit GHRP-6 category page for more information about available product formulations from Direct Peptides New Zealand.

CJC-1295 no DAC

CJC-1295 NO DAC, on the other hand, is a modified version of growth hormone-releasing hormone (GHRH). This peptide works by binding to the GHRH receptor in the anterior pituitary gland, thereby stimulating the release of growth hormone [2].

The absence of DAC (Drug Affinity Complex) in this formulation means that this peptide has a shorter half-life, causing a quicker release of growth hormone, but requiring more frequent dosing [3]. Explore our CJC-1295 no DAC category page to discover detailed insights into its research advantages and potential side effects. Find a variety of product formats available from Direct Peptides New Zealand.


GHRP-6 CJC-1295 No DAC Synergistic Effects

When GHRP-6 CJC-1295 NO DAC are blended together, they provide a synergistic effect, amplifying and strengthening the growth hormone signals to the pituitary gland. This combined action can potentially enhance the overall stimulation of growth hormone release, contributing to improved muscle growth and fat loss.

Moreover, it’s suggested that this blend might aid in the healing of modest muscle and ligament injuries. In addition to its role in muscle growth and fat loss, this peptide blend could also have potential benefits for sleep and the immune system. Growth hormone is known to play a significant role in these areas, so increasing its production could potentially lead to improved sleep quality and enhanced immune function.

Shop ALL Peptide Blends online from Direct Peptides New Zealand today!


Key Features of GHRP-6 CJC-1295 No DAC Blend 2.5mg

  • Promotes GH Release: GHRP-6 stimulates the pituitary gland, leading to increased endogenous growth hormone secretion.
  • Appetite Enhancement: Known for its role in boosting appetite, GHRP-6 is beneficial in studies focused on weight management and nutritional intake.
  • Fat Metabolism: GHRP-6 aids in enhancing fat metabolism, making it a crucial component in research concerning body composition and weight loss.
  • Synergistic Effect: The combination with CJC-1295 No DAC optimally stimulates GHRH receptors, resulting in a sustained elevation of growth hormone levels.
  • Muscle Growth Potential: This blend is instrumental in promoting muscle hypertrophy and recovery, appealing to research in sports medicine and bodybuilding.
  • Anti-Aging Implications: Explores the potential benefits of GH modulation in anti-aging therapies and broader health interventions.
  • Flexible Dosing Strategies: The formulation supports a variety of dosing practices, accommodating diverse experimental needs and protocols.
  • Research Versatility: Valuable for ongoing studies on growth hormone dynamics, metabolic processes, and therapeutic applications in health and performance enhancement.

Shipping and handling

Shipping and handling of the GHRP-6 and CJC-1295 No DAC Blend 2.5mg are conducted under stringent safety regulations, ensuring secure packaging and compliance with legal standards for research materials throughout the transportation process.

Storage Guidelines

To maintain the integrity and potency of the GHRP-6 CJC-1295 No DAC Blend, it is essential to store the product in a refrigerator at a temperature between 2°C and 8°C, away from light and moisture, until it is ready for use.


Reconstitution of GHRP-6 CJC-1295 No DAC Blend 2.5mg

Reconstituting the GHRP-6 CJC-1295 No DAC 2.5mg Blend requires strict sterile techniques. Start by preparing a clean workspace and gathering sterile equipment. Add a diluent like bacteriostatic water to the vial without creating air bubbles, and gently swirl to dissolve the peptide.

After fully dissolving, draw the solution into a sterile syringe for immediate use or store it appropriately. Refrigerate the reconstituted solution at 2°C to 8°C and use it within the recommended timeframe to ensure reliable results in research on growth hormone dynamics.

Shop ALL Peptide Supplies for reconstitution and research online today from Direct Peptides New Zealand.


References:

[1] T Lei, M Buchfelder, R Fahlbusch, and E F Adams (1995) Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells – Journal of Molecular Endocrinology, 1995 Feb, Volume 14 (Issue 1), Pages 135-8.

[2] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, and L A Frohman (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.

[3] B Bumbaca, Z Li, and D K Shah (2019) Pharmacokinetics of Protein and Peptide Conjugates – Drug Metabolism and Pharmacokinetics, Volume 34, Issue 1, February 2019, Pages 42-54.


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Peptides website: https://new-zealand.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


BUY GHRP-6 CJC-1295 No DAC ONLINE today From New Zealand Direct Peptides

You may also like…